Shutterstock
Movement sickness is a disorder that can affect any individual; some people, however - such as women, especially pregnant women, individuals with migraines, and children 2 to 12 years of age - tend to be more prone to the onset of the disorder.
internal (organ responsible for maintaining balance), from the eyes and the proprioceptive system (that is, that system that allows you to recognize the position of your body in space).Symptoms can be triggered by the uneven motion of the body that can occur, in fact, during travel and movement. However, there have also been reports of motion sickness appearing after riding or using elevators, or - albeit less commonly - cases of motion sickness that appeared after watching videos with particularly shaky shots or even after playing some types of video games. .
The risk factors that can favor the onset of motion sickness are fear, anxiety, migraines, annoying noises, excessive heat and poor ventilation of the means of transport in which you are.
For further information: Motion sickness , vomiting and dizziness. In addition to these, however, other symptoms may also appear, such as cold sweat, hyperventilation, hypersalivation, paleness and drowsiness. In addition, some individuals may experience migraines, fatigue and weakness, confusion and a sense of fainting. For further information: Motion sickness symptoms .In more severe cases of motion sickness, however, it may be necessary to resort to drugs.
Generally, over-the-counter or OTC medicines based on dimenhydrinate are used to prevent and control the symptoms of the disorder. In some cases, however, the doctor may consider prescribing cinnarizine-based antivertigenic medicines to the patient. The main characteristics of these active ingredients will be briefly described below.
Before that, however, we would like to point out that in the past, for the treatment of motion sickness, medicines based on scopolamine - an antimuscarinic active ingredient - were also available in the form of medicated plasters (Transcop®) to be applied behind the ear. issue is no longer on the market since 2014 due to revocation upon waiver by the holder of the Marketing Authorization (AIC).